108 related articles for article (PubMed ID: 8722218)
1. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study.
Franco E; Bergeron J; Villa L; Arella M; Richardson L; Arseneau J; Stanimir G
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):271-5. PubMed ID: 8722218
[TBL] [Abstract][Full Text] [Related]
2. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
Sasagawa T; Basha W; Yamazaki H; Inoue M
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
[TBL] [Abstract][Full Text] [Related]
3. HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer.
van Bommel PF; van den Brule AJ; Helmerhorst TJ; Gallee MP; Gaarenstroom KN; Walboomers JM; Meijer CJ; Kenemans P
Gynecol Oncol; 1993 Mar; 48(3):333-7. PubMed ID: 8385059
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.
Pinto AP; Schlecht NF; Pintos J; Kaiano J; Franco EL; Crum CP; Villa LL
Gynecol Oncol; 2004 Mar; 92(3):856-65. PubMed ID: 14984953
[TBL] [Abstract][Full Text] [Related]
5. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.
Dong SM; Pai SI; Rha SH; Hildesheim A; Kurman RJ; Schwartz PE; Mortel R; McGowan L; Greenberg MD; Barnes WA; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):3-6. PubMed ID: 11815394
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus-31-related types predict better survival in cervical carcinoma.
Huang LW; Chao SL; Hwang JL
Cancer; 2004 Jan; 100(2):327-34. PubMed ID: 14716768
[TBL] [Abstract][Full Text] [Related]
9. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
10. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L
Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
[TBL] [Abstract][Full Text] [Related]
13. Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy.
Nagai Y; Toma T; Moromizato H; Maehama T; Asato T; Kariya K; Kanazawa K
Am J Obstet Gynecol; 2004 Dec; 191(6):1907-13. PubMed ID: 15592271
[TBL] [Abstract][Full Text] [Related]
14. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
15. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
16. [Detection of HPV-DNA in the various uterocervical lesion by the in situ polymerase chain reaction].
Ishi K; Kina K; Koyatsu J; Kawashima T; Suzuki F; Saito A; Kubota T; Igari J
Rinsho Byori; 1997 Jan; 45(1):82-6. PubMed ID: 9022348
[TBL] [Abstract][Full Text] [Related]
17. Detection and typing of human papillomavirus in cervical cancer in the Thai.
Bhattarakosol P; Poonnaniti A; Niruthisard S
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S56-64. PubMed ID: 9071068
[TBL] [Abstract][Full Text] [Related]
18. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
19. [Detection of human papillomavirus DNA in cervical squamous cell carcinoma in Xinjiang Uygur women].
Suzuk L; Noffsinger AE; Aili M
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):405-8. PubMed ID: 9639725
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of human papillomavirus type 58 in Chinese patients with cervical carcinoma and its influence on survival.
Shah W; Hongwei C; Jin Z; Lifang D; Jun Y; Yili W
Clin Oncol (R Coll Radiol); 2009 Dec; 21(10):768-74. PubMed ID: 19875274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]